Mitsubishi Tanabe v. Novartis

Paul Hastings advised Mitsubishi Tanabe on the deal. Mitsubishi Tanabe obtained a victory in an international arbitration brought by Novartis. The arbitration involved the multi-billion-dollar-a-year blockbuster drug...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

LinQuest’s Acquisition of CAMO

Morrison Foerster advised LinQuest Corporation on the deal. LinQuest Corporation announced its acquisition of Capability Analysis & Measurement Organization, LLC (CAMO), which provides U.S. Special Operations...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Sendinblue’s Acquisition of Captain Wallet

Paul Hastings advised Sendinblue during the acquisition. Sendinblue, a leader in digital marketing, has acquired Captain Wallet, a pioneering and leading mobile wallet marketing start-up. This...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

KKR’s Investment in Groundworks

Simpson Thacher is advising funds managed by KKR, and Paul Hastings is advising Groundworks. KKR has announced their agreement to significantly invest in Groundworks LLC. The transaction,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Keensight’s Acquisition of Onventis

DLA Piper and Paul Hastings advised Keensight Capital on the deal. POELLATH advised Main Capital Partners. Keensight Capital executed the acquisition of Onventis, a leading provider of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Probio’s Series C Financing

Paul Hastings LLP advised GenScript Biotech Corporation and and its subsidiary Probio Technology Limited on the deal. GenScript ProBio announced its Series C round of financing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here